# FACE Phase II (a Stage II Trial)

> **NCT07130669** · PHASE1,PHASE2 · RECRUITING · sponsor: **Stanford University** · enrollment: 80 (estimated)

## Conditions studied

- MCI
- Subjective Cognitive Decline (SCD)
- Mild Behavioral Impairment

## Interventions

- **BEHAVIORAL:** Cognitive Remediation
- **BEHAVIORAL:** Cognitive Remediation II

## Key facts

- **NCT ID:** NCT07130669
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07130669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07130669, "FACE Phase II (a Stage II Trial)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07130669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*